New drug combo aims to fight breast cancer with less chemotherapy
NCT ID NCT07290166
Summary
This study is testing a combination of targeted drugs given before surgery to treat a specific type of breast cancer that is both hormone-sensitive and HER2-positive. The goal is to see if this approach can effectively control the cancer while reducing the need for traditional chemotherapy. The trial will enroll 42 women with stage II-III breast cancer to evaluate both effectiveness and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.